Iron Triangle Partners LP In its 13F for Q4 2024 (holdings as of December 31, 2024, filed February 14, 2025), Iron Triangle Partners LP reported 22 stock positions worth $857.9 million . Its top holding was Agilent Technologies (A) at 9.3% of the portfolio, followed by Globus Medical Class A (GMED, 8.1% ) and Abbvie (ABBV, 7.7% ). Compared with Q3 2024, it opened 13 new positions, sold out of 15, added to 6 and reduced 3. The biggest buy was a new position in Agilent Technologies (A) and the biggest sale an exit from Elanco Animal Health (ELAN).
Location Cos Cob, CT
CIK 0001779763
Portfolio Value $857.9M (Q4 2024) Holdings 22 stocks · $857.9M Holdings quarter Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock % Of Portfolio ▼ Shares Held Total Value Change vs Q3 2024 A Agilent Technologies Inc. 596,326 $80.1M New GMED Globus Medical Inc. Class A 844,013 $69.8M New ABBV Abbvie Inc. 374,012 $66.5M New UNH Unitedhealth Group Inc. 120,700 $61.1M New TEVA Teva Pharmaceutical-SP ADR 2,200,036 $48.5M Add +13.2% BSX Boston Scientific Corp. 495,009 $44.2M New NBIX Neurocrine Biosciences Inc. 318,195 $43.4M New NVST Envista Holdings Corp. 2,200,000 $42.4M Add +0.5% PODD Insulet Corp. 154,014 $40.2M Add +40.0% MMSI Merit Medical Systems Inc. 407,022 $39.4M Add +60.9% ISRG Intuitive Surgical Inc. 75,000 $39.1M Add +4.2% DVA Davita Inc. 260,424 $38.9M New EXAS Exact Sciences Corp. 600,000 $33.7M Add +50.0% HQY Healthequity Inc. 335,614 $32.2M New MEDP Medpace Holdings Inc. 90,000 $29.9M Reduce -53.3% TWST Twist Bioscience Corp. 492,471 $22.9M Reduce -3.4% XBI SS SPDR S&P Biotech ETF 250,000 $22.5M New GKOS Glaukos Corp. 150,000 $22.5M Reduce -31.1% CAH Cardinal Health Inc. 186,002 $22.0M New ARGX Argenx SE - ADR 35,000 $21.5M New WAY Waystar Holding Corp. 551,893 $20.3M New DOCS Doximity Inc. Class A 312,575 $16.7M New
Options reported separately and not counted above: UNH calls ($50.6M).
Portfolio Sells Q3 2024 → Q4 2024 Portfolio Sells quarter Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock Change vs Q3 2024 % Of Portfolio Change To Portfolio ▲ ELAN Elanco Animal Health Inc. Sold out 0.00% −8.81 ILMN Illumina Inc. Sold out 0.00% −8.07 THC Tenet Healthcare Corp. Sold out 0.00% −7.22 ACHC Acadia Healthcare Co. Inc. Sold out 0.00% −7.15 MEDP Medpace Holdings Inc. Reduce -53.3% 3.49% −5.57 OSCR Oscar Health Inc. Class A Sold out 0.00% −4.81 DHR Danaher Corp. Sold out 0.00% −4.30 AXSM Axsome Therapeutics Inc. Sold out 0.00% −3.19 GERN Geron Corp. Sold out 0.00% −2.14 SNY Sanofi-ADR Sold out 0.00% −2.12 BKD Brookdale Senior Living Inc. Sold out 0.00% −2.10 INSM Insmed Inc. Sold out 0.00% −1.85 ACAD Acadia Pharmaceuticals Inc. Sold out 0.00% −1.62 MYGN Myriad Genetics Inc. Sold out 0.00% −1.55 GKOS Glaukos Corp. Reduce -31.1% 2.62% −1.37 INDV Indivior Ltd. Sold out 0.00% −1.16 BCAX Bicara Therapeutics Inc. Sold out 0.00% −0.72 TWST Twist Bioscience Corp. Reduce -3.4% 2.67% −0.57
Portfolio Buys Q3 2024 → Q4 2024 Portfolio Buys quarter Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock Change vs Q3 2024 % Of Portfolio Change To Portfolio ▼ A Agilent Technologies Inc. New 9.34% +9.34 GMED Globus Medical Inc. Class A New 8.14% +8.14 ABBV Abbvie Inc. New 7.75% +7.75 UNH Unitedhealth Group Inc. New 7.12% +7.12 BSX Boston Scientific Corp. New 5.15% +5.15 NBIX Neurocrine Biosciences Inc. New 5.06% +5.06 DVA Davita Inc. New 4.54% +4.54 HQY Healthequity Inc. New 3.75% +3.75 XBI SS SPDR S&P Biotech ETF New 2.62% +2.62 CAH Cardinal Health Inc. New 2.56% +2.56 ARGX Argenx SE - ADR New 2.51% +2.51 WAY Waystar Holding Corp. New 2.36% +2.36 DOCS Doximity Inc. Class A New 1.95% +1.95 PODD Insulet Corp. Add +40.0% 4.69% +1.09 MMSI Merit Medical Systems Inc. Add +60.9% 4.59% +1.07 TEVA Teva Pharmaceutical-SP ADR Add +13.2% 5.65% +0.73 EXAS Exact Sciences Corp. Add +50.0% 3.93% +0.10 ISRG Intuitive Surgical Inc. Add +4.2% 4.56% −0.41 NVST Envista Holdings Corp. Add +0.5% 4.95% −1.14
Options Activity Q3 2024 → Q4 2024 Security Type Change vs Q3 2024 Underlying Shares Value ▼ UNH Unitedhealth Group Inc. call New 100,000 $50.6M ELAN Elanco Animal Health Inc. call Sold out 723,600 $10.6Mbefore exit
Calls and puts are listed by the shares they cover; their value is not part of the stock holdings above.
All Filings Quarter Positions 13F Reported Value Top Holdings Q4 2025 27 $874.7M CRL, ISRG, RGEN, JAZZ, VCYT Q3 2025 25 $703.3M CVS, DXCM, ABBV, MDT, CRL Q2 2025 26 $631.9M CVS, CRL, ABBV, MMSI, ICLR Q1 2025 27 $634.4M DVA, CAH, ABBV, TEVA, BSX Q4 2024 22 $857.9M A, GMED, ABBV, UNH, TEVA Q3 2024 24 $711.2M MEDP, ELAN, ILMN, THC, ACHC Q2 2024 24 $954.0M EW, DXCM, GKOS, ACHC, ISRG Q1 2024 28 $966.4M ACHC, DXCM, ICLR, ABBV, ISRG